New Approaches to Treating B-Cell Cancers Induced by Epstein–Barr Virus
- 5 February 2015
- journal article
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 372 (6), 569-571
- https://doi.org/10.1056/nejmcibr1415117
Abstract
Two preclinical studies show that boosting numbers of T cells or rendering T cells resistant to the immunosuppressant tacrolimus are potential approaches for the treatment of post-transplantation lymphoproliferative disease associated with EBV infection.Keywords
This publication has 3 references indexed in Scilit:
- Towards gene therapy for EBV-associated posttransplant lymphoma with genetically modified EBV-specific cytotoxic T cellsBlood, 2014
- Targeted Activation of Human Vγ9Vδ2-T Cells Controls Epstein-Barr Virus-Induced B Cell Lymphoproliferative DiseaseCancer Cell, 2014
- Post-transplant lymphoproliferative diseasePediatric Nephrology, 2009